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ABSTRACT 
Logarithmically growing HeLa cell monolayers were treated with a range of concentrations 
of puromycin aminonucleosidc (AMS). The cffects of AMS were studied by the following 
means: microscope examination of treated cells; enumeration of the cell  number using an 
electronic particle counter; analyses for DNA, RNA, and protein content; incorporation of 
p3~  and H~-thymidine into nucleic acids;  and fractionation of nucleic acids by  column 
chromatography. Taking the rate of incorporation of the isotopic precursor as a measure of 
nucleic acid synthesis,  it was found that concentrations of the inhibitor which had a rapid 
effect on the rate of cell division inhibited the synthesis of all types of nucleic acids and of 
protein, but depressed  ribosomal RNA synthesis most markedly. Lower concentrations of 
AMS selectively  inhibited ribosomal RNA and, to a lesser extent, transfer RNA synthesis. 
Partial inhibition of ribosomal RNA synthesis  with low doses had no effect on the rate of 
cell division within the period studied (3 generation times). The ccll content of RNA re- 
turned to normal when the inhibitor was removed. 
INTRODUCTION 
Hydrolytic  cleavage  of  puromycin  produces  a 
nucleosidelike fragment structurally analogous to 
adenosine and known as aminonucleoside  of puro- 
mycin  (AMS)  (Fig.  1).  This  compound  shares 
some  of  the  biological properties  of  puromycin, 
notably its antitrypanosomal and antiparasitic ef- 
fects (17, 28), and is even more effective  than the 
parent compound in the production of the neph- 
rotic syndrome in the rat (14). The potential clini- 
cal importance of this finding stimulated intensive 
investigations  of the action of AMS, but, although 
several  plausible hypotheses of the mechanism of 
its action have been advanced (3, 4, 9, 20), there 
is, as yet, no general agreement on the biochemi- 
cal basis for the observed biological effects of this 
antimetabolite. It is clear,  however,  that,  unlike 
puromycin, AMS is not a specific inhibitor of pro- 
tein biosynthesis ( 1, 18,  27, 31). Work with isolated 
mammalian  mitochondria  indicates  that  AMS 
may  interfere  with  phosphorylation mechanisms 
(3,  4),  and  experiments with  E.  coli show  that 
AMS  inhibits nucleic  acid  synthesis in  this  or- 
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FIGURE 1  Comparison of the structural formulas of 
ganism  (9),  probably  as  a  consequence  of its in- 
hibitory action on purine biosynthesis. 
The experiments reported here were performed 
on HeLa cells,  and it was found that, while high 
concentrations of AMS  inhibited the  synthesis of 
all types of nucleic acids and of protein, lower con- 
centrations of AMS  produced  selective inhibition 
of RNA  synthesis.  In  particular,  ribosomal RNA 
(rRNA)  synthesis  was  most  markedly  inhibited, 
with  lesser  inhibition  of  transfer  RNA  (sRNA), 
while  DNA-like  RNA  (D-RNA)  moieties  were 
least affected.  It was also  shown that when AMS 
was  used  in concentrations which  produced  only 
partial  depression  of  ribosomal  RNA  synthesis, 
HeLa cells continued to divide at the control rate, 
although  their RNA  content  was  decreased. 
The biochemical and growth experiments to be 
presented here were performed together with cyto- 
chemical studies of the inhibited cells, and the next 
paper in this series will describe the morphological 
aspects  of this  work.  These  results  have  already 
been briefly reported  (32,  34). 
METHODS 
7'issue  Culture 
A  wild  strain  of  HeLa  cells  originally  obtained 
from Dr. J. J.  Freed was grown in Petri dishes in a 
humidified  CO2  incubator  as  described  previously 
(33).  Some of  the  Petri  dishes  contained coverslips 
which were used for staining and  microscope exami- 
nation  of the cell monolayer growing on them.  For 
biochemical and growth  studies  the  cells were  har- 
vested from Petri dishes, and the cells in each experi- 
mental group were pooled.  The cell number was ob- 
tained  by  counting  three  aliquots  from  the  pooled 
suspension in  an electronic particle counter  (Model 
B,  Coulter  Electronic  Co.,  Hialeah,  Florida).  The 
N(CHs}2 
Aminonucleoside 
puromyein and aminonueleoside. 
observations reported here were made on cells in the 
logarithmic phase of culture growth. AMS and puro- 
mycin dihydrochloride (Nutritional Biochemical Co., 
Cleveland,  Ohio)  were  added  to  the  cultures  dis- 
solved in the medium. 
Biochemical  Procedures 
Nucleic  acids  were  estimated  by  a  modified 
Schmidt-Thannhauser procedure (13), scaled down to 
require  approximately  a  million  cells  per  sample. 
Protein  content  was  measured  by  the  method  of 
Lowry  (25),  using crystalline egg albumin as stand- 
ard.  Nuclei  were  obtained  by  treatment  with  cold 
citric acid, with the precautions described previously 
(33).  For  column  chromatography  of nucleic  acids, 
the cells were exposed to P3Z-labeled  orthophosphate 
for different time periods  as indicated in the results. 
After labeling, the cells were lysed into a  2% solution 
of sodium dodecyl sulphate and extracted twice with 
phenol  (11),  the interphase being removed with the 
aqueous phase after the first extraction, and left with 
the  phenol  phase  after  the  second  extraction.  The 
nucleic acids were precipitated and chromatographed 
on  methylated  bovine  serum  albumin-Kieselguhr 
(MAK)  columns,  essentially as  described previously 
(11).  It was found, after exposure to AMS, that the 
P~2-1abeled  nucleic  acid  preparation  extracted from 
the cells contained large  amounts  of low  molecular 
weight  phosphorylated  materials.  These  caused  un- 
duly high backgrounds of acid-soluble isotope,  thus 
contaminating the eluted nucleic acids. To eliminate 
this, the solutions of the nucleic acids from both con- 
trols  and AMS-treated  cells were  passed through  a 
G-25  Sephadex  column  equilibrated  with  0.3  M 
Tris  buffered  sodium  chloride  (pH  6.7)  containing 
10  -8 M EDTA, at 0°C, before application to the MAK 
column. 
The eluted nucleic acids were located by continu- 
ous UV and scintillation-scanning devices recording 
on a two-pen chart recorder equipped with an event 
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:FIouRE ~  Inhibition of division of HeLa 
cells by aminonucleoside compared  with 
the  inhibitory effect  of  puromycin.  On 
molar basis,  aminonucleoside is approxi- 
mately ~00  times less powerful inhibitor 
of cell division than puromycin.  Concen- 
trations  of  aminonucleoside  of  3  ~tg/ml 
or  less  had  no  discernible effect  on the 
rate of  cell division in this group  of  ex- 
periments, each performed in triplicate. 
* ~g/ml. 
marker.  The tubes containing the respective nucleic 
acids  were  pooled,  the  volumes  measured,  and  the 
optical density at 260 m~ read.  The p32 incorporated 
into each fraction was  determined  on  aliquots  in  a 
low  background  end-window  counter.  For  studies 
involving the  use  of H3-thymidine,  replicate  plates 
were exposed to  medium containing  16.5  /ZM thymi- 
dine  and 4  ~u: of H3-thymidine per  ml for the same 
time  as  the  parallel  p32  exposure  (60  min).  The 
thymidine was  used  at  this concentration to  ensure 
"saturating concentration" conditions when the rate 
of thymidine incorporation is independent of its con- 
centration (8,  16). The medium was removed and the 
cell  monolaycr  washed  with  Hanks'  balanced  salt 
solution.  The cells were  harvested into a  solution of 
EDTA in balanced salt (26), and then centrifuged at 
3000  RPM  for  5  rain.  The  pellet  was  extracted  five 
times with 5% trichloroacetic acid, digested with 0.5 
N KOH  for  20  hr  at  37°C,  and finally precipitated 
with 0.6 N perchloric acid.  The DNA-protein pellet 
was extracted with 0.6 N perchloric acid at 90°C for 
20 rain,  and the washings of the protein pellet were 
combined with the extract.  Aliquots of all the solu- 
tions were  then counted  in Bray's solution  (6)  in  a 
liquid scintillation spectrometer. The quenching of all 
the DNA samples was found to be the same, so that no 
correction  was  made for  it.  The  DNA  content  was 
estimated by Button's procedure  (7). 
RESULTS 
Inhibition  of Cell Division  by 
Aminonudeoside 
Puromycin aminonucleosidc was a lcss powerful 
inhibitor of HcLa  cell  multiplication  than  puro- 
mycin  (Fig.  2).  Concentrations of 3  ~g/ml  (1.02 
X  10  -5 M) or less did not inhibit the increase in the 
number of cells per culture within the time period 
studied  (ca.  100 hr). Ten #g/ml  allowed the nor- 
mal growth rate to proceed for 72 hr,  after which 
time  there was  partial  inhibition of cell  division. 
Concentrations  of  the  inhibitor  higher  than  10 
~g/ml led to retardation of cell division which was 
apparent at 24 hr of treatment. This was followed, 
after an interval, by a  decrease in the cell number 
per  culture,  indicating  that cell  detachment  and 
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FIGURE  S  Reversibility  of  the  growth  inhibitory 
effect  of  aminonucleoside.  If  aminonueleoside  is  re- 
moved  after  48  hr  of  treatment,  HeLa  cells  resume 
growth after a lag period of approximately ~4 hr. 
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Effect of Arninonucleoside  on the Distribution of Mitotic Stages in Cultures o/ 
HeLa Cells 
Total No. of  Distribution of mitotic stages+  + 
mitotic figures per 
Treatment of the cultures  1000 cells*  Prophase  ]kletaphase  Anaphase  Telophase 
None  25.5  12  59  6  23 
30 gg AMS for 24 hr  25.0  4  40  4  52 
None  38.0  13  52  14  21 
100 #g AMS for 24 hr  15.0  14  23  13  50 
* Arithmetical means ot counts of 1000 mononucleated cells in three replicate cultures. 
~C %  of the total number of mitotic figures. 
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Fmulm  4  Effects  of'  aminonueleoside on  HeLa  cell  multiplication and  maeromoleeular  syntheses. 
Cell DNA content is not affected, protein content is lowered slightly by growth inhibitory concentrations 
of aminonucleoside, but cell RNA content is markedly affected,  even at concentrations which have no 
effect  on the rate of cell multiplication. The values are arithmetical means of four experiments which 
showed essentially the same pattern in each case. 
degeneration exceeded  the rate of cell muhiplica- 
tion. 
The inhibition of cell division produced by AMS 
was not a result of processes immediately lethal to 
the cell, since established growth inhibition could 
be reversed by removal of the medium containing 
AMS and substitution of a  normal medium (Fig. 
3).  The  resumption  of  cell  multiplication  took 
place rather  slowly at first,  but attained the  pre- 
treatment rate  48  hr after the removal of the in- 
hibitor. 
Microscope  examination  of  treated  cultures 
showed that AMS was not a spindle poison nor did 
it cause visible chromosome damage. Thus, recta- 
phase arrest was not seen, abnormal mitoses were 
encountered with a  frequency no  higher  than in 
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Comparison  o/ the RNA Content of Isolated  Nuclei 
and  Unfractionated  Cells  Treated  with 
Aminonudeoside  for 48 hr 
Whole cells  Isolated nuclei 
,ug RNA/10  %  of  /zg RNA/ 10  %  of 
,ug DNA*  control  ,ug DNA*  control 
Control  33.6  100.0  8.2  100.0 
AMS 3 #g/  25.0  74.5  6.2  75.6 
ml 
AMS 30 #g/  18.1  53.9  4.1  50.0 
ml 
* Arithmetical  means  of values  obtained  in  three 
separate  experiments. 
the control cultures, and chromosome clumping or 
lagging chromosomes was rare.  A  few mitotic fig- 
ures could be seen even after prolonged treatment 
with  high doses  of AMS,  when  the cell  numbers 
per culture were decreasing e.g.  72 hr of treatment 
with  AMS  at  100  #g/ml.  In  some  experiments, 
treatment  with  growth-inhibitory  concentrations 
of AMS resulted in a  proportion of mitotic figures 
greater  than would  be expected  from the culture 
growth  rate  or  the  rate  of  DNA  synthesis.  Dif- 
ferential count of the various mitotic stages showed 
a  higher proporUon of telophases in such cultures 
(Table I), indicating that the relatively high num- 
ber of mitotic figures noted was caused by slowing 
of the last stage  of mitosis,  or  a  partial  telophase 
arrest. 
Effects  of Aminonucleoside  on  Nucleic  Acid 
and  Protein  Metabolism  Studied  by 
Biochemical  Methods 
EFFECTS  ON  CELL  NUCLEIC  ACID  and 
I)ROTEIN  CONTENT 
When  HeLa  cell  monolayers  were  treated  with 
concentrations  cf  AMS  ranging  from  3/zg/ml  to 
100 ttg/ml (1.02  X  l0  -5 to 3.40  X  l0  "4M) and the 
cultures  were  analyzed  at intervals for  their con- 
tent of DNA,  total RNA and total protein, it was 
found that the antimetabolite produced inhibition 
of synthesis of DNA  and  protein in proportion  to 
the severity of inhibition of the rate of cell division. 
Consequently,  the  cell  content of DNA  and  pro- 
tein remained close to the value obtained for cells 
from  untreated  cultures  (Fig.  4).  In  contrast,  in- 
hibition  of  RNA  production  was  considerably 
more marked, being apparent after treatment with 
concentrations  of  AMS  which  produced  no  in- 
hibition of the growth rate,  and  this resulted in a 
consistent decrease in RNA content per cell  (Fig. 
4).  Higher  concentrations  of  AMS  lowered  cell 
RNA  content  to  approximately  50%  of the con- 
trol  value  (Table  II). 
The constancy of DNA content per cell during 
AMS  treatment  allowed  the  use  of  DNA  as  a 
reference in terms of which other cell constituents 
could  be  expressed.  The  ratio  of  the  other  cell 
values  to  DNA  then  becomes  equivalent  to  ex- 
pressing these values on a  per cell basis. This fea- 
ture was, therefore, utilized for presentation of sub- 
sequent  results. 
Unlike the DNA content, the protein content of 
AMS-treated  cells was  not invariant,  but the  de- 
crease was only slight and observed only after the 
higher  concentrations  of AMS  (Fig.  4).  The  re- 
suits shown in TaMe III demonstrate that the total 
protein  content  of  cultures  could  increase  for  a 
time under conditions in  which there was  no net 
RNA synthesis (AMS at 30/~g/ml).  Furthermore, 
net protein  synthesis could proceed  at the control 
rate when the net synthesis of RNA  was partially 
inhibited by AMS  at 3  /~g/ml.  Cell  samples from 
AMS-treated cultures gave a  spuriously high color 
by the Lowry  method if not extracted  with TCA 
in the Schmidt-Thannhauser procedure, indicating 
Effects 
TABLE  III 
of  Aminonucleoside  on  Increases  in  Net 
RNA and Protein  Contents  of HeLa 
Cell  Cultures 
#g RNA per culture  ,ug Protein per 
culture 
Content*  Increase Content*  Increase 
Content  at  the  be- 
ginning of the 
experiment 
60.6 
%  % 
454 
After 24 hr of treat- 
ment with : 
No  treatment  111.2  83  806  78 
AMS 3 ~g/ml  102.8  69  820  81 
AMS  10 #g/ml  91.7  51  795  75 
AMS 30 #g/ml  60.7  0  625  38 
* Arithmetical  means  of  values  obtained  in  four 
experiments. 
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FmtraB 5  Readjustment of cell RNA content after removal of aminonueleoside. When the inhibitor is 
replaced  by normal medium,  the cell RNA  content returns gradually to  the control level, but these 
alterations in the rates of RNA synthesis do not affect the rate of cell division. Mean values of three separate 
experiments are shown in the charts. 
an accumulation of an interfering substance as the 
result of AMS  action. 
Analyses performed in parallel on isolated nuclei 
and on unfractionated cells showed that the loss of 
RNA  per cell or per nucleus was proportionately 
the same (Table II). This showed by inference that 
the  decreases  in  RNA  content  in  the  cytoplasm 
and  in  the  nucleus  of  the  cell  were  equal.  50% 
appeared to be the maximal value for the decrease 
in RNA without incurring the loss of structural in- 
tegrity, since increasing the concentration of AMS 
or  the  duration  of treatment failed  to  lower  the 
RNA content of the surviving cells below this level. 
When  AMS  was  removed  from  the  cells'  en- 
vironment, the RNA content returned to the con- 
trol value. For instance, cultures treated with AMS 
at 3/~g/ml continued to grow at the control rate, 
although  the  RNA  content  became lowered;  re- 
moval of AMS from such cultures resulted in the 
return  of cell  RNA  content  to  the control  value 
(Fig.  5). 
SELECTIVITY OF  AMS  EFFECT  ON  THE 
NUCLEIC  ACIDS 
The amount of radioactively labeled precursor in- 
corporated into the different types of nucleic acid 
in  a  given  time  was  used  to  estimate  the  rate  of 
synthesis of the  different  nucleic  acids.  Different 
precursors were used to check the possible effect of 
AMS  on  pool  size.  The  nucleic  acids  were  sepa- 
rated  in  order  of  elution  from  the  column  into 
sRNA,  DNA,  ribosomal  and ribosomal  precursor 
(Q0  RNA,  and  two  types  of  DNAlike  RNA-- 
one  eluted  by  salt  (Q~-RNA)  (11,  36),  and  the 
second major part tenaciously bound to the MAK 
and in need of vigorous elution methods (D-RNA) 
(11).  D-RNA  was eluted with 2 %  sodium  dodec- 
ylsulphate in 0.05 M Tris-HC1 pH 6.7  in  two  steps 
(at 35°C  and the remainder at 70°C)  rather than 
with hot saline as was previously used  (11). 
Fig. 6 illustrates the patterns of incorporation of 
ps2,  during  a  l-hr  period,  into  control  cells  and 
cells treated  for  48  hr  with  a  relatively low  con- 
centration of AMS.  The  most notable  effect was 
the relative depression of incorporation into ribo- 
somal and ribosomal precursor  (QI) RNA.  When 
the incorporation of ps~ was measured (Table IV), 
it  was  found  that,  relative  to  that  of  DNA,  the 
labeling  of  the  ribosomal-Q1  complex  had  de- 
creased  some 2- to 4-fold in different experiments 
as a result of AMS treatment, while sRNA was less 
affected,  and  the  DNAlike  RNA  fractions  were 
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FIGURE 6  Actual tracings of the chart records of the nucleic acids eluted from MAK columns with a 
linear gradient of NaC1 from 0.3 ~  to 1.6 M. The linear gradient was terminated at the points indicated 
by arrows, and tenaciously bound D-RNA was eluted in two steps, only the first of which is shown in 
the figure.  Since different amounts  of nucleic acid were chromatographed and different volumes of salt 
used to elute them, the magnitudes of the values on the chart are not comparable. The important feature 
is the relative depression of 1  ~2 incorporation into the ribosomal-Q1  complex, relative to DNA and Q2, of 
the nucleic acids from the cells treated with AMS (6 #g/ml). 
least  affected.  However,  it  was  found  that  the 
amount of incorporation of p32 into DNA and D- 
RNA  during  short  exposures  to  the  radioactive 
precursor  (1  hr,  which is approximately 1/~6th of 
the cell-doubling time) was actually increased rel- 
ative to the control cells, despite the independently 
demonstrable  decrease  in  net  synthesis  of RNA 
(Table  III). 
As  an  additional  measure  of nucleic  acid  syn- 
thesis, it was decided to observe the incorporation 
of HS-thymidine into DNA in replicate dishes,  in 
parallel with those used for p32 incorporation.  It is 
clear from Table  V  that  AMS alters the relative 
incorporation  rates  of p32  and  HS-thymidine into 
DNA.  AMS at  a  moderate  concentration,  which 
caused the gradual inhibition of cell multiplication, 
resulted  in progressive decrease  in the amount  of 
incorporation,  in  1  hr,  of the  HS-thymidine  into 
DNA  (Table  V,  DNA values in columns headed 
"Corrected").  The  effect  was  small  at  24  hr 
(15.4% inhibition) but marked after 72 hr (49.0% 
inhibition),  p32  incorporation,  while depressed  at 
24 hr, actually increased above control levels at 48 
and  72 hr, as was also seen in Table IV. Since the 
cell  growth  at  this  concentration  was  depressed 
after 24 hr, H3-thymidine  incorporation  indicated 
the state of DNA synthesis, while the the p3~ incor- 
poration was altered by changes either  in  the  pu- 
rine  pool  size  or,  perhaps,  in  the  uptake  of 
p32  into  the  cells  in  the  presence  of AMS,  such 
as  has  been  seen  with  3-'deoxyadenosine  (22). 
By  assuming  that  the  incorporated  ps2  was 
present  in  ribotides  with  the  same  activity  as 
in  deoxyribotides,  though  it  must  be  admitted 
that  support  for  this  assumption  is  not  at  pres- 
ent  available,  the  percentage  incorporation  of 
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Effects of Aminonucleoside*  on  p32  Incorporation$  into HeLa  Cell Nucleic  Acids 
Nucleic acid 
Control  AMS 24 hr  AMS 48 hr 
p32 Incorp.  Incorp. rel.  p~2 Incorp.  Incorp. rel.  p82 Incorp.  Incorp. tel. 
CPM/OD  to DNA  CPM/OD  to DNA  CI'M/OD  to DNA 
DNA§  Incorp.  DNA  Incorp.  DNA  Incorp. 
sRNA  5,137  0.82  5,840  0.28  6,486  0.47 
DNA  6,279  1.00  20,734  1.00  13,741  1.00 
r  +Q~RNA[I  21,670  3.45  16,222  0.78  12,085  0.88 
D-RNA**  36,243  5.77  75,874  3.66  63,561  4.63 
* Concentration  of AMS was  10 ~g/ml. 
:~ Incorporation  during 70-min exposure to isotope at 160 Nc/ml. 
§ The values for the isotope incorporation were normalized by dividing the measured values  by the total 
DNA recovered  from the MAK  column;  they are thus expressed as counts per minute of  p32 per optical 
density unit  (260 m#) of DNA. 
II Ribosomal  q-  ribosomal  precursor  RNA. 
** DNA like RNA  is the sum of Q2 and tenaciously bound RNA. 
TABLE  V 
Effects of Aminonucleoside  on Rates  of Synthesis*  of Nucleic Acids of HeLa  Cells 
Incorporation of pae as % of control incorporation 
AMS 24 hr  AMS 48 hr  AMS 72 hr 
Control p~2 Incorp. 
Nucleic acids  cPM/OD DNA  Observed§  Corrected1]  Observed  Corrected  Observed  Corrected 
sRNA  3,087  49.5  68.3  124.1  47.9  106,4  33.6 
DNA  6,765  61.4  84.6  194.1  74.9  161,3  51.0 
r  +  Q1RNA  13,811  29.9  41.3  83.9  32.4  78.2  24.7 
D-RNA  39,616  69.8  96.2  142.5  55.0  135.0  42.7 
* Duration  of isotope  incorporation  was 60  rain.  p32  concentration  was  160  Nc/ml; AMS  concentration 
was 6  Ng/ml.  The batch of AMS used in this experiment proved  to have markedly higher potency  than 
the batches of AMS purchased  previously and  used  in other  experiments reported  here. 
:~ Designation of nucleic  acid  fractions  as in Table  IV. 
§ Incorporation  of P~. 
[I  Correction  based  on  H3-thymidine uptake.  The DNA  %  incorporation  was  the  actual  incorporation 
of H3-thymidine observed, and the RNA %  incorporation values were adjusted by the factor of difference 
between  the p32 and Ha-thymidine incorporation  values for DNA. 
p32  into  RNA  was  corrected  by  making  the  same 
fractional adjustment to the observed values as was 
necessary  to  correct  the  p3~  incorporation  figures 
for DNA to those observed with H3-thymidine. The 
corrected  RNA  synthesis rates  show  that  the  in- 
hibition  of  the  different  species  was  greatest  in 
ribosomal RNA  and least in DNAlike RNA.  At 24 
hr  of AMS  treatment,  ribosomal  RNA  synthesis 
was decreased  more than twofold,  while  DNAlike 
RNA  was  still  being  synthesized  at  the  control 
rate. 
The  effect of AMS  was not immediate.  After  1 
hr of exposure  to  10  gg/ml,  the  p32  incorporated 
during  a  further 40 rain  showed the values for  all 
nucleic acids to be within 5% of the control values, 
with  the  exception  of  the  ribosomal  complex, 
which exhibited  a  scarcely significant 8 %  depres- 
sion. 
CORRELATION OF THE OBSERVED  NET SYNTHESIS 
Of  RNA  WITH  ISOTOPICALLY  DETER~INED 
RATES  OF  SYNTHESIS 
A  calculation was made  to check whether the pro- 
posed reduction in the rate of rRNA  synthesis was 
commensurate  with the observed net reduction  of 
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Correlation  of Net RNA Synthesis  with the Rate of Incorporation  of Isotope  into RNA 
sRNA  Ribosomal RNA  DNA-like RNA 
8.8  81.0  10.2  Proportion of the species  of 
RNA  as  percentage  of 
total RNA* 
Expected increase in 24 hr in 
untreated culture:~ 
Rate of incorporation of p32 § 
as a  percentage of control 
incorporation[[ 
i.e. increase in 24 hr in AMS- 
treated culture 
i.e.  increase in total culture 
RNA  calculated  from the 
rate of incorporation of p~2 
Increase  in  culture  RNA 
found by Schmidt-Thann- 
hauser analysis 
83 
8.8  X  1-~  =  7.3 
6.03  68.3  X  ~  =  64.4 
64.4 
7.3  X  ]~-  =  4.7 
81  M  1~0  =  67.1 
6.03 
41.3  X  6~  =  38.9 
67.1  M ~  =  26.2 
4.7  q-  26.2  +  7.8  =  38.7% 
44.0% 
8.3 
10.2  X  ~  =  8.5 
6.03 
96.2  X  ~  =  90.6 
90.6  8.5  X  ~  =  7.8 
* Calculated from data presented reference 10. 
:~ It was found by direct analysis that untreated HeLa cells of this strain synthesize 83% of their RNA 
in 24 hr (See Table III).  The values are expressed at this stage as %  increase, taking the value  for total 
RNA of untreated cells at 0  time as  100. 
§ From Table V. 
][ The rates are corrected for the fact that treated cultures in this experiment contained 6.03 X  l0 B  cells, 
while controls contained 6.40  N  106 ceils. 
cell  RNA.  The  value  for  RNA  content  of  cells 
treated with AMS obtained by direct analysis was 
close to that calculated from the rate of incorpora- 
tion of the isotope  (TaMe VI).  This makes it un- 
likely that there was an increase in the breakdown 
of ribosomal RNA present in the cells prior to the 
AMS  treatment.  It does  not,  however,  eliminate 
the possibility that there was an increase in the rate 
of degradation  specifically  of the  newly  synthe- 
sized  ribosomal  RNA,  producing  the  greater  de- 
pression of isotope  accumulation  observed in  this 
fraction, as well as the depressed net synthesis. Nev- 
ertheless,  the  simplest  interpretation  of  the  de- 
pressed isotope incorporation  is  that the  synthesis 
of the various RNA types has been inhibited, and 
that ribosomal RNA has been more inhibited than 
the other nucleic acids. 
DISCUSSION 
The studies  reported  here demonstrate that AMS 
acts as an inhibitor of RNA synthesis in the HeLa 
cell.  When  the  concentration of the compound is 
relatively  low,  the  inhibition  of  RNA  synthesis 
is  selective,  affecting  principally  the  synthesis  of 
ribosomal  types  of  RNA.  Higher  concentrations 
(>  10  /zg/ml)  inhibit, in  addition,  the  synthesis 
of  DNA  and'  other  types  of  RNA,  and  subse- 
quently  a  decrease  in  protein  synthesis  is  noted. 
These observations on cultured ceils derived  from 
a  human  carcinoma  are  similar  to  the  finding of 
van Meter et al., in 1956, that the RNA content of 
mammary tumors obtained from mice treated with 
AMS  is considerably  lower  than  that  of  tumors 
from untreated mice (35). Quite recently, Farnham 
found that AMS inhibited incorporation of uridine 
by cultured L  cells under conditions in which up- 
take of thymidine and leucine into macromolecules 
was  not  inhibited  (12).  This  provides  an  inde- 
pendent line of evidence that AMS selectively in- 
hibits RNA synthesis in established lines of cultured 
mammalian  cells. 
A  rather  unexpected  finding  is  the  ability  of 
G. P. STUDZINSKI AND K. A. O. ELLEM  RNA Synthesis  and Cell Division.  I  419 HeLa  cells to continue  their  multiplication  at  an 
unimpaired  rate  while the  syntheses of ribosomal 
RNA and, to a lesser extent, transfer RNA are be- 
ing depressed by AMS. This indicates that there is 
some reserve  potential  in  the  machinery  for  pro- 
tein  synthesis of the HeLa cells, since the protein 
content of cells treated  in  this manner  is not de- 
pressed.  A  degree of stability of the apparatus  for 
protein  synthesis  is  shown  by  treatment  with 
higher  concentrations  of  AMS,  which  result  in 
complete inhibition of net RNA synthesis: the pro- 
tein content of such cultures continues to increase 
for  a  time  (Table  III). 
While  the  continuation  of the  normal  growth 
rate  in  the  face  of  diminished  RNA  content  of 
HeLa cells may appear  to contrast with the situa- 
tion in bacteria,  in which  the total RNA content 
per cell closely parallels the growth rate  (21,  30), 
this may be due  to  the big difference in  time pa- 
rameters between the microbial and metazoan cell 
growth  cycles.  Thus,  in  the  bacterial  systems the 
growth  rates  used  in  the  studies  represent  the 
steady-state situation, several generations  after the 
growth-controlling  environment  has  been  es- 
tablished (29).  In the present system, growth is ob- 
served  for  approximately  2  generations  after  the 
modulating conditions have been introduced. Cells 
grown as monolayers cannot be maintained in uni- 
form  logarithmic  growth  for  more  than  3  or  4 
generations,  so  that  steady-state  conditions  with 
regard  to  growth  rate  and  RNA content  are not 
achieved. On the other hand, our results are closely 
parallel to the finding of Lederberg and Mazia (23) 
that,  in  media  deficient  in  uracil  but  otherwise 
complete, Tetrahymena  pyriforrnis continues to make 
protein, divide, and form normal cells during 20 hr 
of uracil  deprivation,  although  its net RNA con- 
tent  does  not  increase.  Another  analogy,  with 
respect to the case of the HeLa cell dividing nor- 
mally  while  its  production  of ribosomal  RNA  is 
depressed,  is  afforded  by  the  sea  urchin  oocyte, 
which  upon  fertilization forms  new  proteins  and 
divides to the four-cell stage without any significant 
synthesis  of RNA,  and  grows  to  the  32-cell  stage 
with only the production of "messenger" RNA and 
additions of terminal nucleotides to transfer RNA 
(15). These instances and the observations reported 
here show that the cell content of ribosomal RNA 
does not necessarily determine  the rate of growth 
or the rate  of division of at least  some metazoan 
cells. 
There does seem to be a  limit on the reduction 
in  RNA content  that  can  be  produced  in  HeLa 
cells, and this limit is close to 50% of the RNA con- 
tent of untreated cells. In contrast with the findings 
obtained after treatment with puromycin, in which 
case marked decrease of cytoplasmic RNA content 
is accompanied  by only a  minimal change in nu- 
clear  RNA  (33),  the depression  in  RNA content 
after  treatment  with AMS is proportionately just 
as marked in the nucleus as in the cytoplasm. This 
conclusion is subject to the reservation that losses of 
RNA from the nucleus during isolation are greater 
in  nuclei from  the AMS-treated  cultures  than  in 
nuclei from controls, although the different effects 
noted with the related inhibitor puromycin makes 
this  unlikely. 
The  present  observations  on  the  different  di- 
rections taken by the change of rate of incorpora- 
tion  of two different nucleic  acid  precursors  as  a 
result of AMS  treatment  emphasize  the need  for 
coordinated  net  synthesis  and  multiple  precursor 
studies for the determination  of rates of synthesis. 
Although the synthesis of DNA was found to be de- 
creased,  as indicated by both H3-thymidine incor- 
poration and the measurement of net synthesis, the 
rate of incorporation of p3~ was actually increased. 
The increased P~ incorporation could be the result 
of at least two possible changes: the rate of p~2 entry 
into  the cell may have been  markedly  increased, 
and fluctuations in the nucleotide precursor pools 
may  have  facilitated  p~2  entry  into  the  nucleic 
acids.  Klenow  and  Overgaard-Hansen  (22)  have 
observed the stimulation of p32 incorporation  into 
the DNA of Ehrlieh aseites tumor ceils incubated 
with low concentrations of a  similar inhibitor,  3 r- 
deoxyadenosine  (cordycepin).  In  this  case,  they 
attributed the more rapid labeling to a more rapid 
equilibration  of the phosphorus  of the nucleotide 
pool with that of the isotope in the suspending fluid 
(four times faster in the 3~-deoxyadenosine-treated 
cells). This inhibitor, like AMS, also decreases the 
size of the pool of adenine derivatives in  the cell, 
and  diminishing  supplies  of precursors  could  be 
expected to result in a  slowing down of the macro- 
molecular  synthesis  dependent  upon  them.  The 
actual rate of isotope incorporation will thus be the 
algebraic  sum  of  these  two  opposed  factors.  A 
third complexity in the interpretation  of these re- 
sults may arise from intracellular  compartmenta- 
tion  of acid-soluble  pools,  for  which  there  is  in- 
creasing  evidence  (2,  5,  19,  24).  In  particular, 
Behki and Schneider's (5)  demonstration  that the 
acid-soluble deoxyribosidic compounds are present 
in  a  nuclear  compartment  and  Letnansky's  find- 
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ATP pools which equilibrate with exogenous phos- 
phate  at different rates,  raise the  possibility that 
depletion of the intranuclear pools by AMS may 
lead to more rapid supply of high specific activity 
phosphate  from  the cytoplasmic sources of ATP. 
While the isotopic data do not completely rule 
out  the  possibility  of  rapid  degradation  of  the 
newly synthesized ribosomal RNA, we have inter- 
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